Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

Cited by (907)

Items 901–907 of 907

1. Moderated mediation of cerebrospinal fluid fibroblast growth factor 21 and KLB rs17618244 genotype in the association between educational attainment and cognitive function
   Jianxia Lin, Lidong Su, Xiaoyu Yang, Danyang Zhao, Xingguang Luο, Lei HAO, Yanlong Liu, Fan Wang · 2026 · Behavioural Brain Research
2. Plasma FGF21 is associated with intracranial atherosclerotic stenosis in patients with type 2 diabetes mellitus
   Qiongzhang Wang, Xu Zhang, Yuqing Xiao, Si Zhou, Yun Liu, Chenjing Xie, Jiaqi Chen, Shengwei Wu, Ming Kong, Huiqin Xu · 2026 · Frontiers in Neurology
3. Gut microbiota-mediated FGF metabolic axis in the pathogenesis, prevention and treatment of various diseases
   Xianxi Ye, Zhuofan LU, Weiru ZHANG, Xuelian LIU, Hong ZHENG · 2026 · Journal of Zhejiang University (Medical Sciences)
4. The effect of exercise training on fibroblast growth factor 21 in type 2 diabetes patients: A systematic review and meta-analysis
   Mousa Khalafi, Piunik Hovsepian, Faeghe Ghasemi, Mehdi HosseinKhah · 2026 · Journal of Torbat Heydariyeh University of Medical Sciences
5. Targeting receptor tyrosine kinases: from molecular mechanisms to clinical therapeutics
   Kai Wu, Jia Ji, Ting Sun, Dan Lv, Jingying Pan, Mudan Wei, Miaojin Zhu, Minghai Wang, Lanjuan Li, Hangping Yao · 2026 · Signal Transduction and Targeted Therapy
6. Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging
   Laura Salmón‐Gómez, Susanne Keipert, Victoria Catalán, Amaia Rodrı́guez, Sara Becerril, Gema Frühbeck, Javier Gómez‐Ambrosi · 2026 · Molecular Biomedicine
7. FGF23 - a possible Phosphatonin
   Richard Marsell · 2008 · KTH Publication Database DiVA (KTH Royal Institute of Technology)